Trial
NCT00022633
S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
SWOG Cancer Research Network
Collaborators
National Cancer Institute (NCI)
Condition
Bladder Cancer
Intervention
gemcitabine hydrochloride
Why stopped
Permanently Closed Due to Poor Accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-08-11